NDC codes

FDA NDC Directory
Product NDC (as listed)68180-516Labeler and product segments. Claims need a package NDC.
Product NDC at billing width68180-0516Add the package segment from the table below.

Product information

Brand name (proprietary)
Lisinopril
Generic name (nonproprietary)
lisinopril
Active ingredients
Lisinopril — 30 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 077321
Marketing start
Listing expires
Other FDA classes
Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers
Product ID 68180-516_6723a96d-02f8-40c2-95ec-89a7053a7117SPL ID 6723a96d-02f8-40c2-95ec-89a7053a7117SPL set ID 7d6c31e2-b5a4-4279-8013-a8dad37ea73bRxCUI 197884, 205326, 311353, 311354, 314076, 314077UNII E7199S1YWRUPC 0368180513018, 0368180512028, 0368180513032

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Lisinopril tablet USP is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1.1 ) Adjunct therapy for heart failure ( 1.2 ) Treatment of Acute Myocardial Infarction ( 1.3 ) 1.1 Hypertension Lisinopril tablet USP is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic class…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077321

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077321
ProductStrengthForm · routeLabelerProduct NDC
LisinoprilLisinopril 20 mg/1TabletOralNuCare Pharmaceuticals,Inc.68071-5143
LisinoprilLisinopril 20 mg/1TabletOralLupin Pharmaceuticals, Inc.68180-515
LisinoprilLisinopril 2.5 mg/1TabletOralLupin Pharmaceuticals, Inc.68180-512
LisinoprilLisinopril 20 mg/1TabletOralQPharma, Inc.42708-165
LisinoprilLisinopril 5 mg/1TabletOralLupin Pharmaceuticals, Inc.68180-513
LisinoprilLisinopril 10 mg/1TabletOralLupin Pharmaceuticals, Inc.68180-514
LisinoprilLisinopril 40 mg/1TabletOralLupin Pharmaceuticals, Inc.68180-517
LisinoprilLisinopril 40 mg/1TabletOralQPharma, Inc.42708-176
LisinoprilLisinopril 10 mg/1TabletOralREMEDYREPACK INC.70518-0468
LisinoprilLisinopril 10 mg/1TabletOralA-S Medication Solutions50090-7022
LisinoprilLisinopril 40 mg/1TabletOralProficient Rx LP63187-237
LisinoprilLisinopril 20 mg/1TabletOralREMEDYREPACK INC.70518-0544
LisinoprilLisinopril 10 mg/1TabletOralCardinal Health 107, LLC55154-8078
LisinoprilLisinopril 2.5 mg/1TabletOralQuallent Pharmaceuticals Health LLC82009-062
LisinoprilLisinopril 40 mg/1TabletOralQuallent Pharmaceuticals Health LLC82009-066
LisinoprilLisinopril 10 mg/1TabletOralNorthwind Health Company, LLC51655-995
LisinoprilLisinopril 40 mg/1TabletOralBluePoint Laboratories68001-486
LisinoprilLisinopril 5 mg/1TabletOralQuallent Pharmaceuticals Health LLC82009-063
LisinoprilLisinopril 10 mg/1TabletOralQuallent Pharmaceuticals Health LLC82009-064
LisinoprilLisinopril 20 mg/1TabletOralQuallent Pharmaceuticals Health LLC82009-065

Showing 20 of 39.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in